EP Patent

EP2049518B1 — Indazole and isoindole derivatives as glucokinase activating agents.

Assigned to Takeda California Inc · Expires 2011-08-31 · 15y expired

What this patent protects

Compounds are provided which have the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture which contain such compounds, methods and intermediates useful for making the compounds, and methods of usin…

USPTO Abstract

Compounds are provided which have the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture which contain such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to activate glucokinase.

Drugs covered by this patent

Patent Metadata

Patent number
EP2049518B1
Jurisdiction
EP
Classification
—
Expires
2011-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Takeda California Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.